Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jun 21;23(6):1097-104.
doi: 10.1021/tx1000738.

Characterization of aziridinylbenzoquinone DNA cross-links by liquid chromatography-infrared multiphoton dissociation-mass spectrometry

Affiliations

Characterization of aziridinylbenzoquinone DNA cross-links by liquid chromatography-infrared multiphoton dissociation-mass spectrometry

Sarah E Pierce et al. Chem Res Toxicol. .

Abstract

DNA cross-linking was evaluated by liquid chromatography-tandem mass spectrometry to determine the relative cross-linking abilities of two aziridinylbenzoquinones. Reactivities of RH1 (2,5-diaziridinyl-3-[hydroxymethyl]-6-methyl-1,4-benzoquinone), a clinically studied antitumor cross-linking agent, and an analogue containing a phenyl group (2,5-diaziridinyl-3-[hydroxymethyl]-6-phenyl-1,4-benzoquinone, PhRH1) rather than a methyl group were compared. The bulky phenyl substituent was added to determine the impact of steric hindrance on the formation of cross-links within a double helical structure. Cross-links formed by RH1 and PhRH1 were observed at 5'-dGNC sites as well as 5'-dGAAC/dGTTC sites. RH1 was more effective at forming cross-links than PhRH1 for a variety of duplexes. Infrared multiphoton dissociation (IRMPD) and collision-induced dissociation results confirmed the presence and the location of the cross-links within the duplexes, and IRMPD was used to identify the dissociation pathways of the cross-linked duplexes.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Aziridinyl benzoquinones.
Figure 2
Figure 2
Selected mass spectra from LC-MS experiments for RH1 (a–d) and PhRH1 (e–h) after reaction with DS4. Elution times were as follows: a. 19.66–20.4 min., b. 28.54–29.76 min, c. 33.57–34.43, d. 16.73–17.49 min., e. 19.17–19.73 min., f. 28.88–30.53 min., g. 40.54–41.55, and h. 15.84–16.33 min. RH1 monoadducts are noted by ▲ and crosslinks are noted by ■ and PhRH1 monoadducts are noted by △ and crosslinks by □.
Figure 3
Figure 3
Relative percentages of crosslink formation for RH1 and PhRH1.
Figure 4
Figure 4
CID (a) vs. IRMPD (b) spectra for [DS3+RH1]6−. Ssa and ssb refer to the single strands as described in Table 1. The irradiation time for IRMPD was 5 ms. Fragments from ssa are in bold italics.
Figure 5
Figure 5
IRMPD spectra for selected crosslinked duplexes. Dissociation spectrum from [DS4+RH1]6− after 5 ms irradiation time and dissociation spectrum from [DS5+RH1]6− after 3 ms irradiation time. Fragments from ssa are in bold italics. Fragments containing the crosslink are noted by ■.
Figure 6
Figure 6
Time-variable IRMPD of [DS4+RH1]6−.
Figure 7
Figure 7
Major fragmentation pathways for duplexes crosslinked with RH1 or PhRH1.
Scheme 1
Scheme 1
Reduction mechanism and possible crosslink structure for RH1. Adapted from ref. .
Scheme 2
Scheme 2
Fragmentation process of a duplex with an interstrand crosslink at two guanine bases after IR irradiation.

Similar articles

Cited by

References

    1. Martinez R, Chacon-Garcia L. The Search of DNA-Intercalators as Antitumoral Drugs: What Worked and What Did Not Work. Curr. Med. Chem. 2005;12:127–151. - PubMed
    1. Ferguson LR, Denny WA. Genotoxicity of Non-Covalent Interactions: DNA Intercalators. Mutat. Res.-Fundam. Mol. Mech. Mutagen. 2007;623:14–23. - PubMed
    1. Nelson SM, Ferguson LR, Denny WA. Non-Covalent Ligand/DNA Interactions: Minor Groove Binding Agents. Mutat. Res.-Fundam. Mol. Mech. Mutag. 2007;623:24–40. - PubMed
    1. Li HH, Aubrecht J, Fornace AJ. Toxicogenomics: Overview and Potential Applications for the Study of Non-Covalent DNA Interacting Chemicals. Mutat. Res.-Fundam. Mol. Mech. Mutagen. 2007;623:98–108. - PubMed
    1. Auclair C, Dugue B, Meunier B, Paoletti C. Peroxidase-Catalyzed Covalent Binding of the Antitumor Drug N2-Methyl-9-Hydroxyellipticinium to DNA in Vitro. Biochemistry. 1986;25:1240–1245. - PubMed

Publication types

MeSH terms